T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

Authors:

Abstract
No abstract available

This publication has 18 references indexed in Scilit: